Turn Therapeutics Inc.
TTRX
$13.75
$1.098.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.45M | -3.84M | -3.19M | -3.80M | -2.56M |
| Total Depreciation and Amortization | 56.90K | 54.90K | 52.80K | 51.00K | 49.40K |
| Total Amortization of Deferred Charges | 1.23M | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | -2.05M | -1.79M | 462.40K | 671.60K |
| Change in Net Operating Assets | 1.65M | 1.94M | 2.37M | 1.47M | 232.70K |
| Cash from Operations | -4.32M | -3.90M | -2.56M | -1.82M | -1.60M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.20K | -165.20K | -153.00K | -129.40K | -83.10K |
| Cash from Investing | -139.20K | -165.20K | -168.90K | -145.30K | -99.00K |
| Total Debt Issued | 6.72M | 6.72M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.84M | 6.99M | 6.92M | 4.26M | 3.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.56M | 13.71M | 6.92M | 4.26M | 3.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.10M | 9.65M | 4.20M | 2.32M | 2.30M |